Sign up to access historical data
Similar companies
Company | Est. Transaction Value | |
---|---|---|
PfizerPFE |
-$130,000 | |
AstrazenecaAZN |
-$630,000 | |
ModernaMRNA |
-$59,000 | |
AbbVieABBV |
-$190,000 | |
Eli Lilly and CompanyLLY |
$24,000 |
Trades by US Politicians
Politician | Filing Date | Type | Size |
---|---|---|---|
Marjorie Taylor Greene | Nov 25, 2024 | Buy | $1K - $15K |
Lloyd Doggett | Sep 10, 2024 | Buy | $1K - $15K |
C. Scott Franklin | Aug 7, 2024 | Buy | $15K - $50K |
C. Scott Franklin | Aug 2, 2024 | Buy | $1K - $15K |
Kathy Manning | Jul 2, 2024 | Buy | $1K - $15K |
Jared Moskowitz | Jul 1, 2024 | Buy | $1K - $15K |
Josh Gottheimer | Jun 21, 2024 | Sell | $1K - $15K |
Richard W. Allen | Jun 13, 2024 | Sell | $15K - $50K |
Lloyd Doggett | Jun 4, 2024 | Buy | $1K - $15K |
Kevin Hern | Jun 4, 2024 | Buy | $1K - $15K |
Rohit Khanna Democrat | May 29, 2024 | Buy | $15K - $50K |
Rohit Khanna Democrat | May 28, 2024 | Buy | $15K - $50K |
Rohit Khanna Democrat | Apr 26, 2024 | Sell | $15K - $50K |
Rohit Khanna Democrat | Apr 23, 2024 | Sell | $15K - $50K |
Rohit Khanna Democrat | Mar 25, 2024 | Buy | $1K - $15K |
Rohit Khanna Democrat | Mar 20, 2024 | Buy | $15K - $50K |
Kevin Hern Republican | Mar 5, 2024 | Buy | $1K - $15K |
Lloyd Doggett Democrat | Mar 5, 2024 | Buy | $1K - $15K |
Rohit Khanna Democrat | Feb 13, 2024 | Sell | $15K - $50K |
Rohit Khanna Democrat | Feb 13, 2024 | Sell | $15K - $50K |
Kathy Manning Democrat | Jan 23, 2024 | Buy | $1K - $15K |
Blake Moore Republican | Jan 19, 2024 | Sell | $1K - $15K |
Blake Moore Republican | Jan 19, 2024 | Sell | $1K - $15K |
Rohit Khanna Democrat | Jan 10, 2024 | Buy | $1K - $15K |
Gerald Moran Republican | Dec 14, 2023 | Sell | $1K - $15K |
Gerald Moran Republican | Dec 14, 2023 | Sell | $1K - $15K |
Kevin Hern Republican | Dec 5, 2023 | Buy | $1K - $15K |
Lloyd Doggett Democrat | Dec 5, 2023 | Buy | $1K - $15K |
John James | Nov 10, 2023 | Buy | $1K - $15K |
Rohit Khanna Democrat | Oct 31, 2023 | Sell | $15K - $50K |
Gregory Stanton Democrat | Oct 24, 2023 | Sell | $1K - $15K |
Thomas Tuberville Republican | Oct 16, 2023 | Sell | $1K - $15K |
Rohit Khanna Democrat | Oct 10, 2023 | Buy | $15K - $50K |
Rohit Khanna Democrat | Oct 2, 2023 | Buy | $1K - $15K |
Gregory Stanton Democrat | Sep 26, 2023 | Buy | $1K - $15K |
John Ricketts Republican | Sep 21, 2023 | Sell | $100K - $250K |
John Curtis Republican | Sep 13, 2023 | Sell | $1K - $15K |
Clifford Franklin Republican | Sep 11, 2023 | Sell | $15K - $50K |
Lois Frankel Democrat | Sep 8, 2023 | Sell | $1K - $15K |
Kevin Hern Republican | Sep 7, 2023 | Buy | $1K - $15K |
Lloyd Doggett Democrat | Sep 7, 2023 | Buy | $1K - $15K |
Rohit Khanna Democrat | Sep 6, 2023 | Sell | $50K - $100K |
Sheldon Whitehouse Democrat | Aug 24, 2023 | Buy | $1K - $15K |
Sheldon Whitehouse Democrat | Aug 24, 2023 | Buy | $1K - $15K |
Daniel Sullivan Republican | Aug 22, 2023 | Sell | $1K - $15K |
Lois Frankel Democrat | Aug 10, 2023 | Sell | $1K - $15K |
Michael Guest Republican | Aug 7, 2023 | Buy | $1K - $15K |
Daniel S. Goldman Democrat | Jul 14, 2023 | Sell | $1K - $15K |
Rohit Khanna Democrat | Jun 29, 2023 | Buy | $50K - $100K |
Lloyd Doggett Democrat | Jun 7, 2023 | Buy | $1K - $15K |
Kevin Hern Republican | Jun 6, 2023 | Buy | $1K - $15K |
Rohit Khanna Democrat | May 23, 2023 | Sell | $100K - $250K |
Rohit Khanna Democrat | May 23, 2023 | Buy | $15K - $50K |
Rohit Khanna Democrat | May 19, 2023 | Sell | $1K - $15K |
Rohit Khanna Democrat | Apr 25, 2023 | Sell | $1K - $15K |
Rohit Khanna Democrat | Mar 24, 2023 | Buy | $15K - $50K |
Rohit Khanna Democrat | Mar 14, 2023 | Buy | $50K - $100K |
Lloyd Doggett Democrat | Mar 8, 2023 | Buy | $1K - $15K |
Kevin Hern Republican | Mar 7, 2023 | Buy | $1K - $15K |
Daniel S. Goldman Democrat | Mar 6, 2023 | Buy | $50K - $100K |
Thomas Kean Jr Republican | Feb 24, 2023 | Sell | $15K - $50K |
John Curtis Republican | Feb 23, 2023 | Sell | $1K - $15K |
Rohit Khanna Democrat | Feb 14, 2023 | Sell | $50K - $100K |
Rohit Khanna Democrat | Feb 10, 2023 | Sell | $50K - $100K |
Diana Harshbarger Republican | Feb 10, 2023 | Sell | $1K - $15K |
Lois Frankel Democrat | Feb 8, 2023 | Buy | $1K - $15K |
Daniel S. Goldman Democrat | Feb 3, 2023 | Buy | $1K - $15K |
Daniel S. Goldman Democrat | Jan 31, 2023 | Sell | $100K - $250K |
Kevin Hern Republican | Jan 31, 2023 | Sell | $1K - $15K |
Thomas Kean Jr Republican | Jan 27, 2023 | Sell | $15K - $50K |
Joshua Gottheimer Democrat | Jan 11, 2023 | Sell | $1K - $15K |
Lloyd Doggett Democrat | Dec 7, 2022 | Buy | $1K - $15K |
Rohit Khanna Democrat | Dec 6, 2022 | Buy | $15K - $50K |
Kevin Hern Republican | Dec 6, 2022 | Buy | $1K - $15K |
Who is the latest politician to buy or sell Johnson & Johnson shares?
Marjorie Taylor Greene purchased Johnson & Johnson shares most recently on November 25, 2024.
Which politician has bought the most JNJ stock in the last two years?
Rohit Khanna has bought the most JNJ stock in the last 2 years, with an estimated value of $400,000.
Which politician has sold the most JNJ stock over the last two years?
Rohit Khanna has sold the most JNJ stock in the last 2 years, with an estimated value of $580,000.
What is the total value of politicians trading JNJ stock in the last 2 years?
The net value of trades by US politicians for Johnson & Johnson in the last 2 years is negative, amounting to -$480,000. This suggests that US politicians do not believe in the success of the company for various reasons.
How do insider transactions over the last 2 years reflect on Johnson & Johnson's market confidence?
Over the last 2 years, insider transactions for Johnson & Johnson have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the politicians view on the company's future and growth potential.
Why should individual investors pay attention to the stock transactions of US politicians?
Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.